* Celularity Inc CELU.OQ CELU.O is expected to show a
rise in
quarterly revenue when it reports results on August 7
(estimated).
* The Florham Park New Jersey-based company is expected to
report
a 609.7% increase in revenue to $26.798 million from $3.78
million a year ago, according to the estimate from one analyst,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Celularity Inc is
for a
loss of 3 cents per share.
* The one available analyst rating on the shares is "buy".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Celularity
Inc is
$10.5, above its last closing price of $0.38.
This summary was machine generated August 4 at 13:07 GMT. All
figures in US dollars unless otherwise stated